Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.
Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States. Clin Infect Dis. 2021 11 02; 73(9):e3355-e3357.